Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurochem ; 71(5): 1898-904, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9798913

RESUMO

Ornithine decarboxylase (ODC), the key enzyme for polyamine biosynthesis, dramatically decreases in activity during normal cerebellar development, in parallel with the progressive differentiation of granule neurons. We have studied whether a similar pattern is displayed by cerebellar granule neurons during survival and differentiation in culture. We report that when granule cells were kept in vitro under trophic conditions (high K+ concentration), ODC activity progressively decreased in parallel with neuronal differentiation. Under nontrophic conditions (cultures kept in low K+ concentration), the enzymatic activity dropped quickly in parallel with an increased apoptotic elimination of cells. Cultures kept in high K+ but chronically exposed to 10 mM lithium showed both an increased rate of apoptotic cell death at 2 and 4 days in vitro and a quicker drop of ODC activity and immunocytochemical staining. A short chronic treatment of rat pups with lithium also resulted in transient decrease of cerebellar ODC activity and increased programmed cell death, as revealed by in situ detection of apoptotic granule neurons. The present data indicate that a sustained ODC activity is associated with the phase of survival and differentiation of granule neurons and that, conversely, conditions that favor their apoptotic elimination are accompanied by a down-regulation of the enzymatic activity.


Assuntos
Cerebelo/enzimologia , Neurônios/enzimologia , Ornitina Descarboxilase/metabolismo , Animais , Animais Recém-Nascidos/fisiologia , Apoptose/fisiologia , Diferenciação Celular/fisiologia , Células Cultivadas , Senescência Celular/fisiologia , Cerebelo/citologia , Cerebelo/efeitos dos fármacos , Combinação de Medicamentos , Lítio/farmacologia , Neurônios/citologia , Neurônios/efeitos dos fármacos , Inibidores da Ornitina Descarboxilase , Concentração Osmolar , Potássio/farmacologia , Ratos
2.
Brain Res ; 793(1-2): 54-60, 1998 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-9630513

RESUMO

Microencephalic rats were obtained through gestational (for the forebrain) or neonatal (for the cerebellum) administration of the DNA-alkylating agent methylazoxymethanol acetate (MAM), which selectively kills dividing cells during neurogenesis. In the microencephalic cerebellum the specific activity of calcium-dependent nitric oxide synthase (NOS) was decreased by 35-40% at 12, 28 and 70 days of age. Other neurochemical markers not related to granule cells (the neuronal population selectively compromised by neonatal MAM treatment), choline acetyltransferase (ChAT) and glutamate decarboxylase (GAD) were not decreased, but actually increased when determined as specific activity. In agreement with the decreased catalytic activity measured in the tube, the expression of neuronal NOS protein was attenuated as judged from immunohistochemistry and Western blotting. In the microencephalic forebrain, the specific calcium-dependent NOS activity measured in homogenates of the whole hemisphere was significantly increased as compared to normal animals. Accordingly, immunohistochemistry for neuronal NOS, as well as NADPH-diaphorase histochemistry revealed an apparent increase in the density of strongly reactive neurons in the underdeveloped cortex and striatum of microencephalic rats. The results reported here demonstrate that permanent alterations of neuronal NOS activity and expression occur when the development of the brain and its neuronal circuits are severely compromised. Furthermore, the permanent downregulation of neuronal NOS in the cerebellum of microencephalic rats may be exploited for the study of the role of NO in mechanisms of synaptic plasticity such as long term depression (LTD).


Assuntos
Cerebelo/enzimologia , Microcefalia/enzimologia , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Óxido Nítrico Sintase/metabolismo , Prosencéfalo/enzimologia , Fatores Etários , Animais , Animais Recém-Nascidos , Cerebelo/efeitos dos fármacos , Cerebelo/patologia , Ativação Enzimática/efeitos dos fármacos , Feminino , Injeções Intraperitoneais , Injeções Subcutâneas , Masculino , Acetato de Metilazoximetanol/administração & dosagem , Microcefalia/induzido quimicamente , Microcefalia/patologia , Neurônios/patologia , Óxido Nítrico Sintase/biossíntese , Óxido Nítrico Sintase Tipo I , Tamanho do Órgão/efeitos dos fármacos , Prosencéfalo/efeitos dos fármacos , Prosencéfalo/patologia , Ratos , Ratos Wistar
3.
Neurosci Lett ; 258(1): 1-4, 1998 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-9876037

RESUMO

Pharmacological blockade of the (NMDA) receptor at critical stages of brain development may have long-lasting effects on brain chemistry and on animal behavior. We report here experiments in which the competitive NMDA receptor antagonist CGP 39551 was administered to rat pups from postnatal day 7 (P7) to P18. The stage of treatment was selected to primarily target the cerebellum, whose granule cells undergo post-mitotic migration and establishment of synaptic connections during this period. We focused our study on the long-term consequences of CGP 39551 treatment on the neuronal isoform of nitric oxide synthase (nNOS) since nNOS is highly expressed in the cerebellum and it is functionally linked to the NMDA receptor. Treated rats exhibited a long-lasting (up to P70) decrease in the intensity of nNOS immunocytochemical staining in the cerebellar cortex accompanied by a decrement of calcium-dependent NOS catalytic activity. A comparable decrease of enzyme activity was measured in the cerebral cortex, but not in the hippocampus, of adult rats. Other neurochemical markers (glutamatergic, gabaergic, purinergic) and glutamine synthetase were unchanged, while a cholinergic marker was slightly increased in the cerebellum of CGP 39551 treated animals. Taken together these data show that blockade of NMDA receptor during the critical period of formation and stabilization of neuronal circuits preferentially affects long-term nNOS expression and catalytic activity in the cerebellum.


Assuntos
Cerebelo/enzimologia , Óxido Nítrico Sintase/metabolismo , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , 2-Amino-5-fosfonovalerato/análogos & derivados , 2-Amino-5-fosfonovalerato/farmacologia , Animais , Animais Recém-Nascidos , Benzamidas/farmacologia , Peso Corporal/efeitos dos fármacos , Cerebelo/efeitos dos fármacos , Cerebelo/crescimento & desenvolvimento , Depressão Química , Antagonistas de Dopamina/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Hipercinese/induzido quimicamente , Imuno-Histoquímica , Óxido Nítrico Sintase Tipo I , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Wistar , Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...